| Size & multiples | |||
| Market Cap | $6.87B | Enterprise Value | $6.95B |
| P/E (TTM) | 28.22× | PEG (trailing) | 8.01× |
| P/S | 2.70× | P/FCF | 18.22× |
| EV/EBITDA | 17.64× | EV/EBIT | 21.17× |
| EV/Sales | 2.73× | EV/FCF | 18.42× |
| FCF Yield | 5.49% | Buyback Yield | 8.56% |
| Owner Earnings (TTM) | $259.8M | Owner Earnings Yield | 3.78% |
| Shareholder Yield | 9.04% | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.50 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 6.50% |
| After-tax Cost of Debt | 1.58% | Synthetic credit rating | AAA ⚠ |
| Cost of Debt · embedded (pre-tax) | 2.12% | Cost of Debt · marginal (synthetic) | 4.40% |
| WACC | 6.43% | ROIC | — |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating. ⚠ coverage rests on a very small interest figure; the letter may overstate quality.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $18.34 · revenue TTM $2.54B · FCF TTM $377.1M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E, EV/EBITDA
P/E 57th · EV/EBITDA 58th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 28.2x | 24.4x | 13.0x–39.3x | 57 ↑rich |
| EV/EBITDA | 17.1x | 15.1x | 9.8x–24.4x | 58 ↑rich |
| FCF Yield | 4.7% | -7.8% | -34.7%–1.4% | 86 ↑strong |
| Dividend Yield | 0.5% | 1.1% | 0.2%–2.4% | 31 ↓weak |
| Net Margin | 10.5% | -21.2% | -325.3%–7.2% | 80 ↑strong |
| Operating Margin | 13.4% | -34.5% | -552.0%–8.0% | 83 ↑strong |
| ROE | 25.3% | -36.8% | -92.5%–4.5% | 93 ↑strong |
